Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Internal Medicine

Reuters Health • The Doctor's Channel Daily Newscast

Anti-TNF therapy ups antioxidant effect of HDL cholesterol

NEW YORK (Reuters Health) – In a small study of rheumatoid arthritis patients, treatment with the anti-tumor necrosis factor (anti-TNF) agent infliximab appeared to increase the antioxidative capacity of HDL cholesterol. This finding may help...

Reuters Health • The Doctor's Channel Daily Newscast

Young men with advanced prostate cancer have worse prognosis

NEW YORK (Reuters Health) – Advanced prostate cancer appears to be of a more aggressive type when it occurs in young men, leading to dramatically higher cancer-specific mortality as compared with older men, according to study findings reported in the...

Reuters Health • The Doctor's Channel Daily Newscast

Fenofibrate may reduce amputations in diabetics

NEW YORK (Reuters Health) – Treatment with fenofibrate can reduce the risk of amputation in people with type 2 diabetes by 36%, according to a report in the May 23rd issue of The Lancet. The effect, which is probably mediated through non-lipid...